跳转至内容
Merck
CN

Recent advances in sleep research.

Psychiatria Danubina (2013-11-20)
Bernd Saletu, Peter Anderer, Gerda Maria Saletu-Zyhlarz
摘要

The past two decades have witnessed substantial progress in methodology and knowledge in sleep research all over the world. The paper at hand will present some recent local contributions to this field. The first is a European project (SIESTA) focusing on the creation of an automatic sleep classification system and a normative database, including polysomnographic (PSG) and psychometric measures, in order to make it possible to diagnose sleep-disordered patients as compared with and age- and sex-matched healthy controls between 20 and 95 years of age. Subsequently, two trials on nonorganic sleep disorders in generalized anxiety disorder (GAD) and bruxism, as well as two trials on organic sleep disorders, i.e. snoring/sleep-disordered breathing treated with a mandibular advancement device (I.S.T.) and restless legs syndrome treated with ropinirole and gabapentin, will be discussed.

材料
产品编号
品牌
产品描述

Supelco
加巴喷丁, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
加巴喷丁标准液 CRM 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
加巴喷丁, solid